MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem

被引:11
|
作者
Liu, Ning [1 ]
Yang, Chunsheng [1 ]
Gao, Ang [1 ]
Sun, Meili [1 ]
Lv, Deguan [2 ]
机构
[1] Shandong First Med Univ, Cent Hosp, Dept Oncol, Jinan 250013, Peoples R China
[2] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA
关键词
miR-101; microenvironment; suppressor; proliferation; migration; invasion; apoptosis; therapy; BREAST-CANCER CELLS; GROWTH-FACTOR-C; LUNG-CANCER; INDUCED APOPTOSIS; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; BLADDER-CANCER; COLON-CANCER; PROLIFERATION; MICRORNA-101;
D O I
10.3390/cancers14235861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Abnormal expression of miRNA is often observed in cancer. MiR-101 is closely associated with tumor initiation and progression. In this review, we summarized new findings regarding the role of miR-101 in cancer and the potential mechanisms of targeted gene degradation and microenvironmental regulation. MiRNAs are small single-stranded non-coding RNAs. MiRNA contributes to the transcriptional and post-transcriptional regulation of mRNA in different cell types, including mRNA transcription inhibition and mRNA decay and phenotypes via the effect of several essential oncogenic processes and tumor microenvironment. MiR-101 is a highly conserved miRNA that was found to alter the expression in various human cancers. MiR-101 has been reported to have tumor oncogenic and suppressive effects to regulate tumorigenesis and tumor progression. In this review, we summarize the new findings about the roles of miR-101 in cancers and the underlying mechanisms of targeting genes degradation and microenvironment regulation, which will improve biological understanding and design of novel therapeutics.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] miR-101 Promotes Degradation of Cartilage Matrix in Osteoarthritis
    Cheng, Hao
    Du, Lina
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (11) : 2233 - 2239
  • [22] miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells
    Lin, Chen
    Huang, Fei
    Li, Qiao-Zhi
    Zhang, Ya-Jing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6543 - 6550
  • [23] Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway
    Gao, Ai-Mei
    Zhang, Xiao-Yu
    Ke, Zun-Ping
    ONCOTARGET, 2017, 8 (47) : 82085 - 82091
  • [24] MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1
    Wang, Rui
    Wang, Hong-Bin
    Hao, Chan Juan
    Cui, Yi
    Han, Xiao-Chen
    Hu, Yi
    Li, Fei-Feng
    Xia, Hong-Fei
    Ma, Xu
    PLOS ONE, 2012, 7 (10):
  • [25] MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
    Zhu, Lin
    Chen, Yinan
    Nie, Kai
    Xiao, Yongxin
    Yu, Hong
    CANCER BIOMARKERS, 2018, 23 (02) : 301 - 309
  • [26] Enforced Expression of miR-101 Inhibits Prostate Cancer Cell Growth by Modulating the COX-2 Pathway In Vivo
    Hao, Yubin
    Gu, Xinbin
    Zhao, Yuan
    Greene, Stephen
    Sha, Wei
    Smoot, Duane T.
    Califano, Joseph
    Wu, T. -C.
    Pang, Xiaowu
    CANCER PREVENTION RESEARCH, 2011, 4 (07) : 1073 - 1083
  • [27] Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma
    Shao, Ying
    Li, Peng
    Zhu, Sheng-tao
    Yue, Ji-ping
    Ji, Xiao-jun
    He, Zhen
    Ma, Dan
    Wang, Li
    Wang, Yong-jun
    Zong, Ye
    Wu, Yong-dong
    Zhang, Shu-tian
    PLOS ONE, 2015, 10 (11):
  • [28] Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2
    Wang, Yu
    Zhang, Shulan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1287 - 1293
  • [29] SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer
    Zhang, Xiufeng
    Zhao, Ping
    Wang, Caihong
    Xin, Benru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 510 (04) : 508 - 514
  • [30] A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells
    Ma, Sai
    Cheng, Junping
    Wang, Haiyan
    Ding, Ningling
    Zhou, Feng
    Ji, Runing
    Zhu, Li
    Zhu, Chuanwu
    Pan, Yunzhi
    CARCINOGENESIS, 2021, 42 (01) : 93 - 104